Literature DB >> 9824620

alpha2beta1 integrin signaling via the mitogen activated protein kinase pathway modulates retinoic acid-dependent tumor cell invasion and transcriptional downregulation of matrix metalloproteinase 9 activity.

H P Vo1, M K Lee, D L Crowe.   

Abstract

Tumor cell invasion and metastasis requires precise coordination of adherence to the extracellular matrix (ECM) and controlled degradation of its components. lnvasive cells secrete proteolytic enzymes known as matrix metalloproteinases which degrade specific basement membrane molecules. Expression of these enzymes is regulated by multiple signaling mechanisms, including attachment to the extracellular matrix via integrins. All-trans retinoic acid can inhibit tumor cell invasion of ECM by regulating matrix metalloproteinase expression. Using a series of squamous cell carcinoma lines, we investigated the interactions between integrin and retinoic acid signaling in these cells. In a cell line sensitive to RA-mediated inhibition of invasion, this ligand downregulated MMP-9 activity in cells grown on specific ECM molecules but not on plastic. Inhibition of integrin signaling with anti-alpha1 antibodies or MAPK pathway inhibitors abrogated RA mediated down-regulation of MMP-9 activity and invasion. The effects of RA and MAPK signaling on MMP-9 activity was mediated at the transcriptional level. These data indicate that crosstalk between RA- and integrin dependent signaling pathways regulate MMP activity and invasion in squamous cell carcinoma lines.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9824620     DOI: 10.3892/ijo.13.6.1127

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  7 in total

1.  Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasion.

Authors:  D L Crowe; T N Brown
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

2.  Jun N-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression.

Authors:  D L Crowe; K J Tsang; B Shemirani
Journal:  Neoplasia       Date:  2001 Jan-Feb       Impact factor: 5.715

3.  Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization.

Authors:  A Pozzi; P E Moberg; L A Miles; S Wagner; P Soloway; H A Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

Review 4.  Osteosarcoma metastasis: prospective role of ezrin.

Authors:  Yuanjin Zhang; Ling Zhang; Guofu Zhang; Songbai Li; Jun Duan; Jie Cheng; Guozhen Ding; Chibing Zhou; Jie Zhang; Pengcheng Luo; Dongbing Cai; Lianghong Kuang; Yichun Zhou; Liqun Tong; Xiangdong Yu; Lifang Zhang; Lijun Xu; Li Yu; Xiaomei Shi; Aihong Ke
Journal:  Tumour Biol       Date:  2014-03-09

5.  Fibroblasts and extracellular matrix differently modulate MMP activation by primary and metastatic head and neck cancer cells.

Authors:  Sittichai Koontongkaew; Panomwat Amornphimoltham; Paopanga Monthanpisut; Theeranuch Saensuk; Montira Leelakriangsak
Journal:  Med Oncol       Date:  2011-03-06       Impact factor: 3.064

6.  Extracellular signals regulate rapid coactivator recruitment at AP-1 sites by altered phosphorylation of both CREB binding protein and c-jun.

Authors:  Linh N Tsai; Tony K S Ku; Nader K Salib; David L Crowe
Journal:  Mol Cell Biol       Date:  2008-04-28       Impact factor: 4.272

7.  Recruitment of focal adhesion kinase and paxillin to beta1 integrin promotes cancer cell migration via mitogen activated protein kinase activation.

Authors:  David L Crowe; Arthur Ohannessian
Journal:  BMC Cancer       Date:  2004-05-07       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.